Back to results
US 8,012,482 B2Granted
Humanized anti-TGF-beta antibodies
AssigneeGenentech, Inc.
InventorsCamellia W. Adams, Napoleone Ferrara, Ellen Filvaroff, Weiguang Mao, Leonard G. Presta, Max L. Tejada
Life of this patent
Estimating the term…
Abstract
Humanized anti-TGF-beta antibodies are provided, as well as methods for their preparation and use, including methods for treating TGF-beta disorders, for example, cancer. Also provided are articles of manufacture designed for various uses that contain the humanized antibodies.
Claims26
A humanized antibody that binds a TGF-beta1, TGF-beta2 or TGF-beta3 protein, the humanized antibody comprising:
- a variable heavy (VH) domain that comprises the non-human hypervariable region residues of SEQ ID NO:
- 21, SEQ ID NO:
- 22 and SEQ ID NO:
- 23 incorporated into a human VH domain, said variable domain further comprising a framework region (FR) comprising the framework residues of SEQ ID NO:6 and comprising one or more FR substitutions in SEQ ID NO:6 at a position selected from the group consisting of 48, 49, 68, and 72;
- and
- a variable light (VL) domain chain that comprises complementarity-determining-region (CDR) residues RASQSVLYSSNQKNYLA (SEQ ID NO:18) or RASQGISSYLA (SEQ ID NO:7);
- WASTRES (SEQ ID NO:19) or YASSLQS (SEQ ID NO:8);
- and HQYLSSDT (SEQ ID NO:20).
5 more elements
Dependencies are inferred from the claim text.